Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
jim greenwood
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
3
×
raleigh-durham top stories
regeneron pharmaceuticals
3
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
arches
bristol-myers squibb
david schenkein
debate
digital
donald trump
What
industry
scalps
3
×
american
based
best
bio
continue
crash
debate
healthcare
kind
nash
people
pharmaceutical
policy
politicians
pressure
roundup
trump’s
u.s
administration
angry
anti
benefited
despite
drug
fear
losing
pharma
plans
presidential
price
rhetoric
rx
split
thanks
trump
tweets
Language
Current search:
scalps
×
" raleigh-durham blog main "
×
" regeneron pharmaceuticals "
×
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans